FDA Approved: ACTIMMUNE — Supplemental Application (Horizon Therapeutics USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ACTIMMUNE (interferon gamma-1b) submitted by Horizon Therapeutics USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease
• Osteopetrosis Malignant

Drugs mentioned

• ACTIMMUNE (interferon gamma-1b)

Snippet

SUPPL AP for ACTIMMUNE (INTERFERON GAMMA-1B)